2016 Q4 Form 10-K Financial Statement
#000114420417017265 Filed on March 29, 2017
Income Statement
| Concept | 2016 Q4 | 2016 | 2015 Q4 |
|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Cost Of Revenue | |||
| YoY Change | |||
| Gross Profit | |||
| YoY Change | |||
| Gross Profit Margin | |||
| Selling, General & Admin | $330.0K | $2.830M | $570.0K |
| YoY Change | -42.11% | -21.17% | -44.66% |
| % of Gross Profit | |||
| Research & Development | $320.0K | $2.250M | $830.0K |
| YoY Change | -61.45% | -54.54% | -49.39% |
| % of Gross Profit | |||
| Depreciation & Amortization | $20.00K | $77.00K | $20.00K |
| YoY Change | 0.0% | -11.49% | -33.33% |
| % of Gross Profit | |||
| Operating Expenses | $650.0K | $2.250M | $1.400M |
| YoY Change | -53.57% | -54.54% | -47.57% |
| Operating Profit | -$5.083M | ||
| YoY Change | -40.45% | ||
| Interest Expense | |||
| YoY Change | |||
| % of Operating Profit | |||
| Other Income/Expense, Net | $30.00K | $100.0K | $10.00K |
| YoY Change | 200.0% | 100.0% | -116.67% |
| Pretax Income | -$620.0K | -$1.451M | -$1.380M |
| YoY Change | -55.07% | -48.94% | -49.45% |
| Income Tax | $0.00 | $0.00 | |
| % Of Pretax Income | |||
| Net Earnings | -$620.0K | -$4.982M | -$1.380M |
| YoY Change | -55.07% | -41.31% | -49.45% |
| Net Earnings / Revenue | |||
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$33.17K | -$266.9K | -$74.35K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 18.69M shares | 18.50M shares | |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2016 Q4 | 2016 | 2015 Q4 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $9.990M | $9.990M | $15.96M |
| YoY Change | -37.41% | -37.41% | 86.89% |
| Cash & Equivalents | $547.0K | $550.0K | $428.0K |
| Short-Term Investments | $9.440M | $9.440M | $15.53M |
| Other Short-Term Assets | $150.0K | $150.0K | $70.00K |
| YoY Change | 114.29% | 114.29% | 133.33% |
| Inventory | |||
| Prepaid Expenses | |||
| Receivables | $310.0K | $310.0K | $760.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $10.44M | $10.44M | $16.79M |
| YoY Change | -37.81% | -37.82% | 74.91% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $297.0K | $300.0K | $271.0K |
| YoY Change | 9.59% | 11.11% | -13.42% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $322.0K | $30.00K | $292.0K |
| YoY Change | 10.27% | 50.0% | -12.31% |
| Total Long-Term Assets | $330.0K | $330.0K | $292.0K |
| YoY Change | 13.01% | 13.79% | -6.71% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $10.44M | $10.44M | $16.79M |
| Total Long-Term Assets | $330.0K | $330.0K | $292.0K |
| Total Assets | $10.77M | $10.77M | $17.08M |
| YoY Change | -36.94% | -36.94% | 72.33% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $345.0K | $350.0K | $1.169M |
| YoY Change | -70.49% | -70.09% | -24.19% |
| Accrued Expenses | $150.0K | $150.0K | $1.500M |
| YoY Change | -90.0% | -90.0% | 11.36% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $0.00 | $0.00 | |
| YoY Change | |||
| Total Short-Term Liabilities | $860.0K | $860.0K | $2.952M |
| YoY Change | -70.87% | -70.85% | -5.17% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $0.00 | ||
| YoY Change | -100.0% | ||
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| YoY Change | -100.0% | ||
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $860.0K | $860.0K | $2.952M |
| Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
| Total Liabilities | $864.0K | $860.0K | $2.952M |
| YoY Change | -70.73% | -70.85% | -8.78% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$75.12M | -$70.14M | |
| YoY Change | 7.1% | 13.77% | |
| Common Stock | $85.03M | $84.27M | |
| YoY Change | 0.9% | 23.33% | |
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $9.902M | $9.900M | $14.13M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $10.77M | $10.77M | $17.08M |
| YoY Change | -36.97% | -36.94% | 72.33% |
Cashflow Statement
| Concept | 2016 Q4 | 2016 | 2015 Q4 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$620.0K | -$4.982M | -$1.380M |
| YoY Change | -55.07% | -41.31% | -49.45% |
| Depreciation, Depletion And Amortization | $20.00K | $77.00K | $20.00K |
| YoY Change | 0.0% | -11.49% | -33.33% |
| Cash From Operating Activities | -$1.200M | -$5.858M | -$1.290M |
| YoY Change | -6.98% | -20.94% | -35.82% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $0.00 | $103.0K | -$20.00K |
| YoY Change | -100.0% | 128.89% | -71.43% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $790.0K | $6.080M | $910.0K |
| YoY Change | -13.19% | -154.09% | -133.83% |
| Cash From Investing Activities | $790.0K | $5.977M | $900.0K |
| YoY Change | -12.22% | -152.99% | -132.61% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 0.000 | $0.00 | 110.0K |
| YoY Change | -100.0% | -100.0% | 120.0% |
| NET CHANGE | |||
| Cash From Operating Activities | -1.200M | -$5.858M | -1.290M |
| Cash From Investing Activities | 790.0K | $5.977M | 900.0K |
| Cash From Financing Activities | 0.000 | $0.00 | 110.0K |
| Net Change In Cash | -410.0K | $119.0K | -280.0K |
| YoY Change | 46.43% | -103.12% | -94.07% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$1.200M | -$5.858M | -$1.290M |
| Capital Expenditures | $0.00 | $103.0K | -$20.00K |
| Free Cash Flow | -$1.200M | -$5.961M | -$1.270M |
| YoY Change | -5.51% | -20.04% | -34.54% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2016 | dei |
Entity Voluntary Filers
EntityVoluntaryFilers
|
No | |
| CY2016 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
| CY2015 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
7000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
-1264000 | USD |
| CY2016 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-824000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
|
-373000 | USD |
| CY2015 | us-gaap |
Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
|
212000 | USD |
| CY2015 | bcli |
Increase Decrease In Accounts Receivable And Prepaid Expenses
IncreaseDecreaseInAccountsReceivableAndPrepaidExpenses
|
-204000 | USD |
| CY2016 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.46 | |
| CY2016 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
18663162 | shares |
| CY2015 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
4949000 | USD |
| CY2016 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
2833000 | USD |
| CY2015 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3587000 | USD |
| CY2015 | bcli |
Financial Expenses Income Net
FinancialExpensesIncomeNet
|
-48000 | USD |
| CY2016 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-4982000 | USD |
| CY2015 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-8488000 | USD |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
|
-0.27 | |
| CY2015 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
18405610 | shares |
| CY2015 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-8536000 | USD |
| CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
864000 | USD |
| CY2015Q4 | us-gaap |
Liabilities
Liabilities
|
2952000 | USD |
| CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
85014000 | USD |
| CY2015Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
84258000 | USD |
| CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-75123000 | USD |
| CY2015Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-70141000 | USD |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
9902000 | USD |
| CY2015Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
14128000 | USD |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
10766000 | USD |
| CY2015Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
17080000 | USD |
| CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
11000 | USD |
| CY2015Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
11000 | USD |
| CY2016Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
345000 | USD |
| CY2016Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
25000 | USD |
| CY2015Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
21000 | USD |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
297000 | USD |
| CY2015Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
271000 | USD |
| CY2016Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
322000 | USD |
| CY2015Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
292000 | USD |
| CY2016 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
2250000 | USD |
| CY2015 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2015 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
108000 | USD |
| CY2016 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5083000 | USD |
| CY2015Q4 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
152000 | USD |
| CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
|
55000 | USD |
| CY2016 | dei |
Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
|
No | |
| CY2016 | dei |
Entity Filer Category
EntityFilerCategory
|
Smaller Reporting Company | |
| CY2015 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
835000 | USD |
| CY2015 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
109000 | USD |
| CY2015 | bcli |
Exercise And Reissuance Of Warrants Value
ExerciseAndReissuanceOfWarrantsValue
|
12409000 | USD |
| CY2015 | bcli |
Exercise Of Liability Classified Warrants
ExerciseOfLiabilityClassifiedWarrants
|
145000 | USD |
| CY2015 | bcli |
Exercise Of Equity Classified Warrants
ExerciseOfEquityClassifiedWarrants
|
2333000 | USD |
| CY2015 | bcli |
Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
|
2000 | USD |
| CY2016 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
635000 | USD |
| CY2016 | us-gaap |
Depreciation
Depreciation
|
77000 | USD |
| CY2015 | us-gaap |
Depreciation
Depreciation
|
87000 | USD |
| CY2016 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5858000 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-7408000 | USD |
| CY2016 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
635000 | USD |
| CY2015 | us-gaap |
Stock Option Plan Expense
StockOptionPlanExpense
|
835000 | USD |
| CY2016 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
121000 | USD |
| CY2015 | us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
108000 | USD |
| CY2016 | bcli |
Increase Decrease In Accounts Receivable And Prepaid Expenses
IncreaseDecreaseInAccountsReceivableAndPrepaidExpenses
|
-379000 | USD |
| CY2016 | us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
-6084000 | USD |
| CY2015 | us-gaap |
Payments For Proceeds From Investments
PaymentsForProceedsFromInvestments
|
11237000 | USD |
| CY2015 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-3823000 | USD |
| CY2014Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4251000 | USD |
| CY2015 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
12409000 | USD |
| CY2015 | us-gaap |
Stock Issued1
StockIssued1
|
0 | USD |
| CY2016 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
0 | USD |
| CY2015 | us-gaap |
Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
|
2459000 | USD |
| CY2014Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
800000000 | shares |
| CY2015Q3 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2016 | bcli |
Percentage Of Royalty Paymentif Licensed Product Covered By Valid Claim Or Orphan Drug Status
PercentageOfRoyaltyPaymentifLicensedProductCoveredByValidClaimOrOrphanDrugStatus
|
0.05 | pure |
| CY2016 | bcli |
Validity Of Royalty Payment Not Covered By Valid Claim Or Orphan Drug Status
ValidityOfRoyaltyPaymentNotCoveredByValidClaimOrOrphanDrugStatus
|
P15Y | |
| CY2016 | bcli |
Percentage Of Royalty Payment If Licensed Product Not Covered By Valid Claim Or Orphan Drug Status
PercentageOfRoyaltyPaymentIfLicensedProductNotCoveredByValidClaimOrOrphanDrugStatus
|
0.03 | pure |
| CY2016Q4 | us-gaap |
Grants Receivable Current
GrantsReceivableCurrent
|
154000 | USD |
| CY2015Q4 | us-gaap |
Grants Receivable Current
GrantsReceivableCurrent
|
607000 | USD |
| CY2016Q4 | us-gaap |
Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
|
152000 | USD |
| CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
|
57000 | USD |
| CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
|
43000 | USD |
| CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
|
110000 | USD |
| CY2016 | bcli |
Amounts Of Grants Received
AmountsOfGrantsReceived
|
1669000 | USD |
| CY2015Q4 | bcli |
Share Based Goods And Nonemployee Services Transaction Securities Outstanding Number
ShareBasedGoodsAndNonemployeeServicesTransactionSecuritiesOutstandingNumber
|
891197 | shares |
| CY2014Q4 | bcli |
Share Based Goods And Nonemployee Services Transaction Securities Outstanding Number
ShareBasedGoodsAndNonemployeeServicesTransactionSecuritiesOutstandingNumber
|
863786 | shares |
| CY2016 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
|
36033 | shares |
| CY2015 | us-gaap |
Share Based Goods And Nonemployee Services Transaction Quantity Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionQuantityOfSecuritiesIssued
|
27411 | shares |
| CY2016Q4 | bcli |
Share Based Goods And Nonemployee Services Transaction Securities Outstanding Number
ShareBasedGoodsAndNonemployeeServicesTransactionSecuritiesOutstandingNumber
|
927230 | shares |
| CY2015Q4 | bcli |
Share Based Goods And Non Employee Services Transaction Securities Outstanding Weighted Average Issue Price
ShareBasedGoodsAndNonEmployeeServicesTransactionSecuritiesOutstandingWeightedAverageIssuePrice
|
4.07 | |
| CY2014Q4 | bcli |
Share Based Goods And Non Employee Services Transaction Securities Outstanding Weighted Average Issue Price
ShareBasedGoodsAndNonEmployeeServicesTransactionSecuritiesOutstandingWeightedAverageIssuePrice
|
4.07 | |
| CY2016 | bcli |
Share Based Goods And Nonemployee Services Transaction Weighted Average Issue Price Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionWeightedAverageIssuePriceOfSecuritiesIssued
|
3.35 | |
| CY2015 | bcli |
Share Based Goods And Nonemployee Services Transaction Weighted Average Issue Price Of Securities Issued
ShareBasedGoodsAndNonemployeeServicesTransactionWeightedAverageIssuePriceOfSecuritiesIssued
|
3.94 | |
| CY2016Q4 | bcli |
Share Based Goods And Non Employee Services Transaction Securities Outstanding Weighted Average Issue Price
ShareBasedGoodsAndNonEmployeeServicesTransactionSecuritiesOutstandingWeightedAverageIssuePrice
|
4.04 | |
| CY2015 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-11283000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
0 | USD |
| CY2015 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
14868000 | USD |
| CY2016 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
119000 | USD |
| CY2016 | us-gaap |
Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
|
0 | USD |
| CY2016 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
103000 | USD |
| CY2015 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
45000 | USD |
| CY2016 | bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
4000 | USD |
| CY2015 | bcli |
Investment In Lease Deposit
InvestmentInLeaseDeposit
|
1000 | USD |
| CY2016 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
5977000 | USD |
| CY2016 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
0 | USD |
| CY2015 | us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
130000 | USD |
| CY2016 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
756000 | USD |
| CY2015 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
943000 | USD |
| CY2016 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
1185000 | USD |
| CY2015 | us-gaap |
Research And Development Arrangement Contract To Perform For Others Compensation Earned
ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned
|
1386000 | USD |
| CY2015 | bcli |
Research And Development Cost
ResearchAndDevelopmentCost
|
6335000 | USD |
| CY2016 | bcli |
Research And Development Cost
ResearchAndDevelopmentCost
|
3435000 | USD |
| CY2016Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
39967000 | USD |
| CY2015Q4 | us-gaap |
Operating Loss Carryforwards
OperatingLossCarryforwards
|
34672000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
13333000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Gross
DeferredTaxAssetsGross
|
11778000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
13333000 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
|
11778000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2015Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
0 | USD |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-1451000 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
|
-2842000 | USD |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-3531000 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
|
-5646000 | USD |
| CY2016 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
134000 | USD |
| CY2015 | us-gaap |
Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
|
161000 | USD |
| CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00005 | |
| CY2015Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.00005 | |
| CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
18687987 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
18687987 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
18643288 | shares |
| CY2015Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
18643288 | shares |
| CY2016 | bcli |
Noncash Financing Activities
NoncashFinancingActivities
|
0 | USD |
| CY2015 | bcli |
Noncash Financing Activities
NoncashFinancingActivities
|
130000 | USD |
| CY2014Q3 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
1-for-15 | |
| CY2016 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 1.15in" align="justify"></div> <table style="LINE-HEIGHT: 115%; FONT-FAMILY: Calibri,sans-serif; FONT-SIZE: 11pt" border="0" cellspacing="0" cellpadding="0"> <tr> <td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; PADDING-BOTTOM: 0in; BORDER-TOP-COLOR: #000000; PADDING-LEFT: 0in; WIDTH: 56pt; PADDING-RIGHT: 0in; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;CLEAR: both"></div> </td> <td style="BORDER-BOTTOM-COLOR: #000000; TEXT-ALIGN: left; PADDING-BOTTOM: 0in; BORDER-TOP-COLOR: #000000; PADDING-LEFT: 0in; WIDTH: 34pt; PADDING-RIGHT: 0in; BORDER-RIGHT-COLOR: #000000; VERTICAL-ALIGN: top; BORDER-LEFT-COLOR: #000000; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt"> <strong><font style="FONT-SIZE: 10pt">B.</font></strong></div> </td> <td style="PADDING-BOTTOM: 0in; PADDING-LEFT: 0in; PADDING-RIGHT: 0in; PADDING-TOP: 0in" valign="top"> <div style="CLEAR:both;MARGIN: 0in 0in 0pt; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 12pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Use of estimates:</font></strong></div> </td> </tr> </table> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt 85.05pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0in 1.25in" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2016Q4 | us-gaap |
Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
|
265000 | USD |
| CY2016 | bcli |
Grants Underlying Basis
GrantsUnderlyingBasis
|
The grant is linked to the exchange rate of the dollar and bears interest of Libor per annum. | |
| CY2016 | us-gaap |
Maturity Of Time Deposits
MaturityOfTimeDeposits
|
P1M | |
| CY2015 | us-gaap |
Maturity Of Time Deposits
MaturityOfTimeDeposits
|
P6M | |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1673000 | USD |
| CY2015Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
1568000 | USD |
| CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1376000 | USD |
| CY2015Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
1297000 | USD |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
874841 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
1002451 | shares |
| CY2016 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y4M17D | |
| CY2015 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P7Y5M8D | |
| CY2016Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
839509 | shares |
| CY2015Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
611761 | shares |
| CY2016 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-4982000 | USD |
| CY2015 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-8488000 | USD |
| CY2012Q3 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4900000 | USD |
| CY2009Q4 | us-gaap |
Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
|
74667 | shares |
| CY2015 | bcli |
Corporate Effective Income Tax Rate
CorporateEffectiveIncomeTaxRate
|
0.4 | pure |
| CY2016 | bcli |
Corporate Effective Income Tax Rate
CorporateEffectiveIncomeTaxRate
|
0.4 | pure |
